Canada Pension Plan Investment Board Glaukos Corp Transaction History

Canada Pension Plan Investment Board

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$40.27 - $56.99 $483,240 - $683,880	-12,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$47.43 - $84.23 $569,160 - $1.01 Million	12,000 New	12,000 $578,000
Q3 2020 Nov 12, 2020	SELL	$37.23 - $50.97 $100,520 - $137,619	-2,700 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$28.78 - $46.83 $77,706 - $126,441	2,700 New	2,700 $104,000
Q1 2020 May 13, 2020	SELL	$25.53 - $70.14 $995 - $2,735	-39 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$54.18 - $65.64 $2,113 - $2,559	39 New	39 $2,000

303

47M

75.3K

157K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.07B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.